View Older Stories View More Recent Stories

Apr 13, 2026 05:23PM Form SCHEDULE 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Apr 10, 2026 06:25PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Apr 8, 2026 06:45PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Apr 7, 2026 06:00PM Form SCHEDULE 13G Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Apr 7, 2026 04:14PM Form SCHEDULE 13G OnKure Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Apr 6, 2026 06:55PM Form SCHEDULE 13G Zai Lab Ltd Filed by: RA CAPITAL MANAGEMENT, L.P.

Apr 2, 2026 04:47PM Form SCHEDULE 13G Karyopharm Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.

Apr 1, 2026 05:10PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Apr 1, 2026 07:05AM Cyclerion and Korsana announce $380 million merger deal

Mar 30, 2026 08:38PM Form SCHEDULE 13G Xencor Inc Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 30, 2026 08:32PM Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 27, 2026 08:02AM OnKure raises $150 million to advance cancer treatment programs

Mar 24, 2026 07:02AM Karyopharm raises $30 million in private placement with RA Capital

Mar 23, 2026 04:28PM Form SCHEDULE 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 23, 2026 04:26PM Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 20, 2026 04:13PM Form SCHEDULE 13G Equillium, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 18, 2026 06:00AM Ovid Therapeutics prices $60 million private placement for drug development

Mar 17, 2026 06:50PM Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 17, 2026 04:36PM Form SCHEDULE 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 16, 2026 04:15PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 16, 2026 06:30AM Acumen Pharmaceuticals raises $35.75 million in private placement

Mar 13, 2026 08:01AM Equillium raises $35 million from RA Capital Management

Mar 11, 2026 04:43PM Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 10, 2026 04:39PM Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 9, 2026 07:05AM Relmada Therapeutics raises $160 million in oversubscribed private placement

Mar 6, 2026 08:31AM Solid Biosciences raises $240 million in private placement

Mar 2, 2026 04:25PM Form SCHEDULE 13D/A Bicara Therapeutics Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 2, 2026 08:01AM Rallybio and Candid Therapeutics announce merger agreement

Feb 18, 2026 08:01AM Sensei Biotherapeutics acquires Faeth Therapeutics for $200 million

Feb 17, 2026 07:29PM Form SCHEDULE 13D/A Evommune, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 07:22PM Form SCHEDULE 13D SpyGlass Pharma, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:46PM Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:44PM Form SCHEDULE 13G/A Surrozen, Inc./DE Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:42PM Form SCHEDULE 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:41PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:39PM Form SCHEDULE 13G/A Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:37PM Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:35PM Form SCHEDULE 13G/A Larimar Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:34PM Form SCHEDULE 13G/A Invivyd, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:32PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31

Feb 17, 2026 04:30PM Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:29PM Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:26PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:24PM Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:22PM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:20PM Form SCHEDULE 13G/A Arcellx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:18PM Form SCHEDULE 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:16PM Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 17, 2026 04:05PM Immunic closes $200 million private placement financing

Feb 13, 2026 06:30AM Immunic raises up to $400 million in oversubscribed private placement

View More Recent Stories View Older Stories